Go Unlimited with Magzter GOLD
Get unlimited access to 9,500+ magazines, newspapers and Premium stories for just
Try GOLD - Free
IN CONVERSATION: "We are working with a Vision 2035. I'm sure within next 5 years we will be ranking among the Fortune 500 companies.”
Indian Economy & Market
|November 2024
Sudarshan Pharma Industries Ltd., led by its promoters, Mr. Hemal V. Mehta, a chemical engineer, and Mr. Sachin V. Mehta, has established a strong foundation in specialty chemicals and bulk drugs. Their relentless enthusiasm is visible when they speak. Indian Economy & Market reached out, to piece together the company's achievements and new initiatives in detail.
-
Under PLI Scheme company was awarded two important licenses - B1 & B6. What is the current status?
We were rewarded the project of Aatmanirbhar Bharat Rojgar Yojana Under PLI Scheme and we have successfully achieved our first milestone of developing the sample for the molecule VITAMIN B1 (Thiamine Hydrochloride). It was developed from Base Root till Finish Product and we have successfully manufactured all the Intermediated Products which is required to manufacture the finish API - VITAMIN B1.
We are proud to say that we happened to be the only company that got two API, in one basket under PLI scheme. We developed the products in our R&D and it would be our monopoly products and we have started the process to file for Patent for the manufacturing process and the intermediates. For Vitamin B1 and B6 and other API/ intermediates the production facility is under process and in March 2026 we will finalise the full facility of Mahad plant which is not only for PLI scheme rather it is a multipurpose plant. If we include the recovery of solvent plant, it houses total five plants under one roof. Our projection is to achieve sales of Rs 150 crore in the first year and profit to be above 30% which will reflect in FY26-27.
Ratna Life Sciences presented a significant growth opportunity for the company. What is the future expansion plan that could drive revenue potential?
We acquired 100 per cent stake in Ratna Lifesciences and now it is a wholly owned subsidiary of Sudarshan Pharma. Ratna Lifesciences specialises in oncology products with an existing capacity of two metric tons, expandable to 15 metric tons. The acquisition helped our immediate foray into Oncology products with a manufacturing unit which is already setup, with option to expand further. We believe oncology business to become a major share of revenues over the next 3-5 years.
This story is from the November 2024 edition of Indian Economy & Market.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 9,500+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Indian Economy & Market
Indian Economy & Market
THE RISE OF AGROCHEMICAL INDUSTRY India
A PATHWAY TO GLOBAL LEADERSHIP
5 mins
July 2025
Indian Economy & Market
TRADE WAR: CHINA'S WEAPONISATION OF RARE EARTHS
After Beijing announced new restrictions on exporting rare earth minerals and the specialised magnets they make, the world's auto industry warned of shortages that could force factory closures. China's recent skilful deployment of rare earth sanctions was probably the key factor in forcing Washington to reverse its tariff rises on the country. They represent a new era of Chinese economic statecraft — evidence of a sanctions policy capable of pressuring not only small neighbours but also the world's largest economy.
2 mins
July 2025
Indian Economy & Market
"We are strengthening the MSE ecosystem by enhancing access to collateral-free credit and reducing the credit risk for lenders"
How you feel about this year’s Budget announcements as the head of the CGTMSE? Do you think the finance minister has done justice with your demands/ expectations?
7 mins
July 2025
Indian Economy & Market
RUPEE BATTLES ROUGH TIDES
Why Has the Rupee Weakened So Substantially, And What Does the Future Hold for Its Trajectory?
6 mins
July 2025
Indian Economy & Market
ket Ind Ind SUPER INTELLIGENCE
“Al has been driving the stock market to record highs, but the market has the look and feel of a super-bubble,” says James Rickards. He feels that “the crash could come anytime and bring the market down by 50% or more. That’s not a reason to short the major stock indices today. The bubble can last longer than anyone expects. If you short the indices, you can lose a lot of money being wrong. But it is advisable to lighten up on equity allocations and increase your allocation to cash in order to avoid the worst damage when the crash does come.”
6 mins
July 2025
Indian Economy & Market
SOCIALISM, DEMOCRACY AND ECONOMICS
The 2025 New York City mayoral election is scheduled to be held on November 4, 2025. Incumbent Eric Adams, who was elected as a Democrat, is seeking reelection to a second term as an independent.
6 mins
July 2025
Indian Economy & Market
STRENGTHENING TRUST IN THE STOCK MARKET
Securities and Exchange Board of India's 210th board meeting, held on June 18, 2025, saw the approval of a series of amendments designed to enhance various facets of market regulation and governance. Some of these changes were long overdue, while others—though technical—have the potential to quietly reshape market operations. The reforms are designed to simplify compliance processes, enhance transparency, and promote greater ease of doing business across the capital market ecosystem. Shivanand Pandit discusses in detail.
5 mins
July 2025
Indian Economy & Market
Those 'Emergency Days'
It still haunts me. I can never forget those days. And I'm sure many people, who were young enough to understand and feel the current, will ever forget those 'Emergency' days.
12 mins
July 2025
Indian Economy & Market
Everything You Do or Say is Public Relations
These are uneasy times for anyone who manages anything worth its salt - be it an organization, business, or even self-branding either in a creative field or politics. It is the aftermath of the emergence of management technology that has been adopted almost everywhere and, in every sphere, consciously or otherwise, that has helped transform the way we see, think and act.
3 mins
July 2025
Indian Economy & Market
Strategically Navigating Weaker Global Growth
Global economy is seen running into turbulence as trade and geopolitical uncertainties threaten unwinding the gains of yesteryears. The World Bank, in its Global Economic Prospects (GEP, 2025) report for June 2025, forecasts global growth at 2.3% in 2025, slowest growth reading after 2008 with exception of outright recessions.
3 mins
July 2025
Listen
Translate
Change font size